Annual Accounts Receivable
$3.01 M
+$2.99 M+14940.00%
31 December 2023
Summary:
Vaxart annual accounts receivable is currently $3.01 million, with the most recent change of +$2.99 million (+14940.00%) on 31 December 2023. During the last 3 years, it has risen by +$2.94 million (+4136.62%). VXRT annual accounts receivable is now -91.88% below its all-time high of $37.06 million, reached on 27 December 2003.VXRT Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$591.00 K
-$497.00 K-45.68%
30 September 2024
Summary:
Vaxart quarterly accounts receivable is currently $591.00 thousand, with the most recent change of -$497.00 thousand (-45.68%) on 30 September 2024. Over the past year, it has dropped by -$2.42 million (-80.35%). VXRT quarterly accounts receivable is now -98.69% below its all-time high of $45.05 million, reached on 26 June 2004.VXRT Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VXRT Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -80.3% |
| 3 y3 years | +4136.6% | +732.4% |
| 5 y5 years | -16.9% | -83.7% |
VXRT Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -80.3% | |
| 5 y | 5 years | -16.9% | >+9999.0% | -83.7% | |
| alltime | all time | -91.9% | >+9999.0% | -98.7% |
Vaxart Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $591.00 K(-45.7%) |
| June 2024 | - | $1.09 M(+95.7%) |
| Mar 2024 | - | $556.00 K(-81.5%) |
| Dec 2023 | $3.01 M(>+9900.0%) | $3.01 M(+609.4%) |
| Sept 2023 | - | $424.00 K(+1362.1%) |
| June 2023 | - | $29.00 K(-89.0%) |
| Mar 2023 | - | $264.00 K(+1220.0%) |
| Dec 2022 | $20.00 K(-71.8%) | $20.00 K(>+9900.0%) |
| Sept 2022 | - | $0.00(0.0%) |
| June 2022 | - | $0.00(-100.0%) |
| Mar 2022 | - | $81.00 K(+14.1%) |
| Dec 2021 | $71.00 K(-78.7%) | $71.00 K(-62.6%) |
| Sept 2021 | - | $190.00 K(+77.6%) |
| June 2021 | - | $107.00 K(-84.7%) |
| Mar 2021 | - | $700.00 K(+109.6%) |
| Dec 2020 | $334.00 K(-90.8%) | $334.00 K(+33.6%) |
| Sept 2020 | - | $250.00 K(+10.1%) |
| June 2020 | - | $227.00 K(-91.5%) |
| Mar 2020 | - | $2.66 M(-26.4%) |
| Dec 2019 | $3.62 M(+101.5%) | $3.62 M(+547.4%) |
| Sept 2019 | - | $559.00 K(+1497.1%) |
| June 2019 | - | $35.00 K(-99.4%) |
| Mar 2019 | - | $5.58 M(+210.9%) |
| Dec 2018 | $1.80 M(+199.3%) | $1.80 M(+932.2%) |
| Sept 2018 | - | $174.00 K(-15.1%) |
| June 2018 | - | $205.00 K(-98.3%) |
| Mar 2018 | - | $12.17 M(+386.8%) |
| Dec 2017 | - | $2.50 M(+2400.0%) |
| Sept 2017 | - | $100.00 K(-83.3%) |
| June 2017 | $600.00 K(-14.3%) | $600.00 K(-90.9%) |
| Mar 2017 | - | $6.60 M(+57.1%) |
| Dec 2016 | - | $4.20 M(+600.0%) |
| Sept 2016 | - | $600.00 K(-14.3%) |
| June 2016 | $700.00 K(-94.4%) | $700.00 K(-93.1%) |
| Mar 2016 | - | $10.10 M(+98.0%) |
| Dec 2015 | - | $5.10 M(+59.4%) |
| Sept 2015 | - | $3.20 M(-74.6%) |
| June 2015 | $12.60 M | $12.60 M(+24.8%) |
| Mar 2015 | - | $10.10 M(+44.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2014 | - | $7.00 M(+1300.0%) |
| Sept 2014 | - | $500.00 K(-44.4%) |
| June 2014 | $900.00 K(+800.0%) | $900.00 K(-97.5%) |
| Mar 2014 | - | $36.50 M(+35.7%) |
| Dec 2013 | - | $26.90 M(+108.5%) |
| Sept 2013 | - | $12.90 M(>+9900.0%) |
| June 2013 | $100.00 K(-99.5%) | $100.00 K(-99.3%) |
| Mar 2013 | - | $15.17 M(+33.3%) |
| Dec 2012 | - | $11.38 M(>+9900.0%) |
| June 2012 | - | $0.00(-100.0%) |
| Sept 2007 | - | $14.31 M(-13.2%) |
| June 2007 | - | $16.49 M(-4.1%) |
| Mar 2007 | - | $17.20 M(-15.6%) |
| Dec 2006 | $20.38 M(+3.5%) | $20.38 M(+81.6%) |
| Sept 2006 | - | $11.22 M(-56.1%) |
| June 2006 | - | $25.57 M(-1.2%) |
| Mar 2006 | - | $25.89 M(+31.5%) |
| Dec 2005 | $19.68 M(-39.3%) | $19.68 M(+24.7%) |
| Sept 2005 | - | $15.78 M(-46.1%) |
| June 2005 | - | $29.31 M(+43.4%) |
| Mar 2005 | - | $20.44 M(-36.9%) |
| Dec 2004 | $32.41 M(-12.6%) | $32.41 M(-6.6%) |
| Sept 2004 | - | $34.71 M(-23.0%) |
| June 2004 | - | $45.05 M(+22.1%) |
| Mar 2004 | - | $36.90 M(-0.4%) |
| Dec 2003 | $37.06 M(+2.0%) | $37.06 M(+3.1%) |
| Sept 2003 | - | $35.95 M(+60.0%) |
| June 2003 | - | $22.47 M(-23.7%) |
| Mar 2003 | - | $29.44 M(-19.0%) |
| Dec 2002 | $36.33 M(+0.8%) | $36.33 M(+4.0%) |
| Sept 2002 | - | $34.94 M(+2.1%) |
| June 2002 | - | $34.22 M(+27.3%) |
| Mar 2002 | - | $26.87 M(-25.4%) |
| Dec 2001 | $36.04 M(+57.4%) | $36.04 M(+53.9%) |
| Sept 2001 | - | $23.41 M(-32.0%) |
| June 2001 | - | $34.44 M(+13.8%) |
| Mar 2001 | - | $30.26 M(+32.1%) |
| Dec 1994 | $22.90 M(+76.2%) | $22.90 M(+76.2%) |
| Dec 1993 | $13.00 M | $13.00 M |
FAQ
- What is Vaxart annual accounts receivable?
- What is the all time high annual accounts receivable for Vaxart?
- What is Vaxart quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Vaxart?
- What is Vaxart quarterly accounts receivable year-on-year change?
What is Vaxart annual accounts receivable?
The current annual accounts receivable of VXRT is $3.01 M
What is the all time high annual accounts receivable for Vaxart?
Vaxart all-time high annual accounts receivable is $37.06 M
What is Vaxart quarterly accounts receivable?
The current quarterly accounts receivable of VXRT is $591.00 K
What is the all time high quarterly accounts receivable for Vaxart?
Vaxart all-time high quarterly accounts receivable is $45.05 M
What is Vaxart quarterly accounts receivable year-on-year change?
Over the past year, VXRT quarterly accounts receivable has changed by -$2.42 M (-80.35%)